{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:58Z","timestamp":1790946718304,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtm.2019.10.014","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T19:17:16Z","timestamp":1573499836000},"page":"392-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["AAV-Mediated Gene Augmentation Therapy Restores Critical Functions in Mutant PRPF31+\/\u2212 iPSC-Derived RPE Cells"],"prefix":"10.1016","volume":"15","author":[{"given":"Elizabeth M.","family":"Brydon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Buskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majlinda","family":"Lako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Fernandez-Godino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.10.014_bib1","doi-asserted-by":"crossref","first-page":"e41902","DOI":"10.1371\/journal.pone.0041902","article-title":"Genes associated with retinitis pigmentosa and allied diseases are frequently mutated in the general population","volume":"7","author":"Nishiguchi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.10.014_bib2","first-page":"1659","article-title":"Retinitis pigmentosa: the Friedenwald lecture","volume":"34","author":"Berson","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.10.014_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1097-2765(01)00305-7","article-title":"A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11)","volume":"8","author":"Vithana","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtm.2019.10.014_bib4","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/hmg\/ddr094","article-title":"PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa","volume":"20","author":"Tanackovic","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08820538.2015.1114856","article-title":"Course of ocular function in PRPF31 retinitis pigmentosa","volume":"31","author":"Hafler","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.omtm.2019.10.014_bib6","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.ajpath.2014.06.026","article-title":"Mutations in pre-mRNA processing factors 3, 8, and 31 cause dysfunction of the retinal pigment epithelium","volume":"184","author":"Farkas","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.10.014_bib7","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1093\/hmg\/ddu005","article-title":"PRPF4 mutations cause autosomal dominant retinitis pigmentosa","volume":"23","author":"Chen","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/cge.12203","article-title":"Genes and mutations causing retinitis pigmentosa","volume":"84","author":"Daiger","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1167\/iovs.10-5194","article-title":"Three gene-targeted mouse models of RNA splicing factor RP show late-onset RPE and retinal degeneration","volume":"52","author":"Graziotto","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.10.014_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI34211","article-title":"Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay","volume":"118","author":"Rio Frio","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2019.10.014_bib11","doi-asserted-by":"crossref","first-page":"e1003040","DOI":"10.1371\/journal.pgen.1003040","article-title":"CNOT3 is a modifier of PRPF31 mutations in retinitis pigmentosa with incomplete penetrance","volume":"8","author":"Venturini","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib12","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-018-06448-y","article-title":"Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa","volume":"9","author":"Buskin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2019.10.014_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1471-2164-14-486","article-title":"Transcriptome analyses of the human retina identify unprecedented transcript diversity and 3.5 Mb of novel transcribed sequence via significant alternative splicing and novel genes","volume":"14","author":"Farkas","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.omtm.2019.10.014_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/humu.20325","article-title":"Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations","volume":"27","author":"Rivolta","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2019.10.014_bib15","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1167\/iovs.03-0253","article-title":"Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance?","volume":"44","author":"Vithana","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.10.014_bib16","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.10.014_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11095-018-2554-7","article-title":"Pharmaceutical development of AAV-based gene therapy products for the eye","volume":"36","author":"Rodrigues","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtm.2019.10.014_bib18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/mt.2015.114","article-title":"Gene augmentation therapy restores retinal function and visual behavior in a sheep model of CNGA3 achromatopsia","volume":"23","author":"Banin","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.014_bib19","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/hmg\/ddq136","article-title":"Gene therapy rescues cone function in congenital achromatopsia","volume":"19","author":"Kom\u00e1romy","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib20","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.10.014_bib21","doi-asserted-by":"crossref","first-page":"e94272","DOI":"10.1371\/journal.pone.0094272","article-title":"EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat","volume":"9","author":"Zallocchi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.10.014_bib22","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.10.014_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.09.012","article-title":"Choroideremia gene therapy phase 2 clinical trial: 24-month results","volume":"197","author":"Lam","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omtm.2019.10.014_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtm.2019.10.014_bib25","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1167\/iovs.08-3275","article-title":"Study of gene-targeted mouse models of splicing factor gene Prpf31 implicated in human autosomal dominant retinitis pigmentosa (RP)","volume":"50","author":"Bujakowska","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"128","key":"10.1016\/j.omtm.2019.10.014_bib26","first-page":"e56274","article-title":"Rapid, directed differentiation of retinal pigment epithelial cells from human embryonic or induced pluripotent stem cells","author":"Foltz","year":"2017","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2019.10.014_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/jop.2016.0022","article-title":"Induced pluripotent stem cell-derived retinal pigmented epithelium: a comparative study between cell lines and differentiation methods","volume":"32","author":"Leach","year":"2016","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.omtm.2019.10.014_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"Balazs","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.10.014_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/hum.2017.154","article-title":"Synthetic adeno-associated viral vector efficiently targets mouse and nonhuman primate retina in\u00a0vivo","volume":"29","author":"Carvalho","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.014_bib30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2019.10.014_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1750-1326-6-56","article-title":"Mutant Prpf31 causes pre-mRNA splicing defects and rod photoreceptor cell degeneration in a zebrafish model for Retinitis pigmentosa","volume":"6","author":"Yin","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2019.10.014_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1523\/JNEUROSCI.2399-04.2005","article-title":"Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells","volume":"25","author":"Yuan","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2019.10.014_bib33","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/bioinformatics\/btr427","article-title":"Comparative analysis of RNA-Seq alignment algorithms and the RNA-Seq unified mapper (RUM)","volume":"27","author":"Grant","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2019.10.014_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.33.1.61","article-title":"The renewal of photoreceptor cell outer segments","volume":"33","author":"Young","year":"1967","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.10.014_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/41.2.8419462","article-title":"Phagocytosis of outer segments by retinal pigment epithelium: phagosome-lysosome interaction","volume":"41","author":"Bosch","year":"1993","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2019.10.014_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.celrep.2017.12.038","article-title":"Primary cilium-mediated retinal pigment epithelium maturation is disrupted in ciliopathy patient cells","volume":"22","author":"May-Simera","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2019.10.014_bib37","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.10.014_bib38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.10.014_bib39","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1182\/blood-2010-07-298331","article-title":"Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells","volume":"117","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.10.014_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2019.10.014_bib41","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2019.10.014_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2019.10.014_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2019.10.014_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/hmg\/ddx392","article-title":"Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway","volume":"27","author":"Fernandez-Godino","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2019.10.014_bib46","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","article-title":"A local complement response by RPE causes early-stage macular degeneration","volume":"24","author":"Fernandez-Godino","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.014_bib47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/nprot.2016.065","article-title":"Isolation, culture and characterization of primary mouse RPE cells","volume":"11","author":"Fernandez-Godino","year":"2016","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:07Z","timestamp":1762421107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119301226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"alternative-id":["S2329050119301226"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.10.014","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/729160","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-Mediated Gene Augmentation Therapy Restores Critical Functions in Mutant PRPF31+\/\u2212 iPSC-Derived RPE Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}